|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1985-6-12
|
|
pubmed:abstractText |
In the period June 1980-April 1983, 21 children with malignant disease were admitted because of an intercurrent varicella or zoster infection. They were treated with the new antiviral drug BVDU [(E)-5-(2-bromovinyl)-2'-deoxyuridine]. The drug was administered orally at a dose of 15 mg/kg per day for 5 days. All our patients responded promptly to BVDU treatment and recovered completely from their varicella or zoster infections without complications. No toxic side-effects due to the drug were observed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0340-6199
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
143
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
198-202
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:3987714-Administration, Oral,
pubmed-meshheading:3987714-Adolescent,
pubmed-meshheading:3987714-Animals,
pubmed-meshheading:3987714-Antiviral Agents,
pubmed-meshheading:3987714-Bromodeoxyuridine,
pubmed-meshheading:3987714-Chickenpox,
pubmed-meshheading:3987714-Child,
pubmed-meshheading:3987714-Child, Preschool,
pubmed-meshheading:3987714-Female,
pubmed-meshheading:3987714-Herpes Zoster,
pubmed-meshheading:3987714-Humans,
pubmed-meshheading:3987714-Male,
pubmed-meshheading:3987714-Neoplasms
|
|
pubmed:year |
1985
|
|
pubmed:articleTitle |
Oral BVDU treatment of varicella and zoster in children with cancer.
|
|
pubmed:publicationType |
Journal Article
|
